KalGene Pharmaceuticals
Montréal
About KalGene Pharmaceuticals
KalGene Pharmaceuticals, Inc. is a privately held company working in partnership with many of North America and Europe’s leading clinician-scientists and academic institutions. KalGene is focused on the development of targeted therapeutics and companion diagnostics. Its programs are aimed at improving clinical and survival outcomes through the use of personalized medicine. Personalized medicine seeks to predict which patients will respond to a particular therapy in advance of treatment. This prediction allows physicians to prescribe treatment according to an individual’s specific biological signature, or needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.6M
- Funding stage: Seed
- Last round: Debt Financing (Jun 2021)
- Website: kalgene.com
- Phone: (604) 375-4519
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Precision Medicine
Canonical: https://fsome.com/organization/kalgene-pharmaceuticals-113019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.